Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul;6(7):e1862.
doi: 10.1002/cnr2.1862. Epub 2023 Jul 6.

Unraveling immunotherapy's role in propelling cancer outcomes

Ning Ji  1 , Amit K Tiwari  2 , Dong-Hua Yang  3
Affiliations
Editorial

Unraveling immunotherapy's role in propelling cancer outcomes

Ning Ji et al. Cancer Rep (Hoboken). 2023 Jul.
No abstract available

PubMed Disclaimer

References

    1. Difoum F, Schernberg A, Vanquaethem H, et al. Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: the ToxImmune study. Cancer Reports. 2023;6(7):e1760. doi:10.1002/cnr2.1760 - DOI - PMC - PubMed
    1. Huss R, Raffler J, Märkl B. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology. Cancer Reports. 2023;6(7):e1796. doi:10.1002/cnr2.1796 - DOI - PMC - PubMed
    1. Musha A, Kubo N, Kawamura H, et al. Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy. Cancer Reports. 2023;6(7):e1825. doi:10.1002/cnr2.1825 - DOI - PMC - PubMed
    1. Mahase SS, Roytman M, Roth O'Brien D, et al. Concurrent immunotherapy and re‐irradiation utilizing stereotactic body radiotherapy for recurrent high‐grade gliomas. Cancer Reports. 2023;6(7):e1788. doi:10.1002/cnr2.1788 - DOI - PMC - PubMed
    1. Nair DR, Trehan R. Pembrolizumab induced remission of recurrent and metastatic sinonasal squamous cell carcinoma after overcoming checkpoint‐inhibitor pneumonitis: a case report and literature review. Cancer Reports. 2023;6(7):e1778. doi:10.1002/cnr2.1778 - DOI - PMC - PubMed

Publication types